Markets:

Overview

News

Currencies

International

Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.2475 -0.0024 (-0.96%)

Delayed Quote Updated: 10:49 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

83 Biggest Movers From Yesterday ↗

June 09, 2022

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...

Via Benzinga

A Forgettable Week For Alzheimer's Treatment Stocks ↗

July 30, 2021

Two of our top names that spiked last week come back down to earth. This is why we hedge.

Via Talk Markets

IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders

June 08, 2022

From India Globalization Capital, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 03, 2022

Good morning! We're preparing for another busy day of trading with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits

April 18, 2022

From India Globalization Capital, Inc.

Via Business Wire

64 Biggest Movers From Friday ↗

March 28, 2022

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed...

Via Benzinga

36 Stocks Moving In Friday's Mid-Day Session ↗

March 25, 2022

Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported...

Via Benzinga

34 Stocks Moving in Friday's Pre-Market Session ↗

March 25, 2022

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22...

Via Benzinga

Cannabis Stocks That Moved On News That Federal Cannabis Legalization Bill Heads To House For Vote Next Week ↗

March 24, 2022

The House of Representatives intends to vote on a bill to federally legalize cannabis for the second time in history next week, congressi...

Via Benzinga

India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors

March 23, 2022

From India Globalization Capital, Inc.

Via Business Wire

India Globalization Capital Posts Net Loss Of $2.38M For The Third Quarter ↗

February 11, 2022

India Globalization Capital, Inc. (AMEX:IGC) announced its financial results for the three months ending December 31, 2021 – quarter three of the company’s 2022 fiscal year. Q3 Financial Highlights

Via Benzinga

IGC Reports Financial Results for the December 31, 2021 Quarter

February 10, 2022

From India Globalization Capital, Inc.

Via Business Wire

India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors

January 19, 2022

From India Globalization Capital, Inc.

Via Business Wire

IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials ↗

December 14, 2021

India Globalization Capital, Inc. (NYSE: IGC) announced Tuesday that it had received positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a...

Via Benzinga

Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

December 14, 2021

From India Globalization Capital, Inc.

Via Business Wire

IGC Trials Research Effective THC Drug Dosing For Alzheimer's Patients ↗

December 09, 2021

India Globalization Capital, Inc. (AMEX:IGC) revealed th...

Via Benzinga

Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients

December 08, 2021

From India Globalization Capital, Inc.

Via Business Wire

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

December 02, 2021

From India Globalization Capital, Inc.

Via Business Wire

Potential Cannabis Unicorn "InterCure" Realizes the 7th Consecutive Quarter of Revenue Growth ↗

December 01, 2021

Former prime minister of Israel and InterCure chairman Ehud Barak at the company’s market open from their cultivation site in Israel...

Via Benzinga

Topics Cannabis

IGC Posts Q2 Results, Reveals Promising Results From Clinical Trial Of THC-Drug For Alzheimer's Symptoms ↗

November 01, 2021

India Globalization Capital, Inc. (AMEX:

Via Benzinga

IGC Reports Financial Results for the September 30, 2021 Quarter

October 29, 2021

From India Globalization Capital, Inc.

Via Business Wire

IGC Announces Results of its 2021 Annual Stockholders Meeting

October 15, 2021

From India Globalization Capital, Inc.

Via Business Wire

21 Stocks Moving in Wednesday's Pre-Market Session ↗

September 08, 2021

Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) rose 75.7% to $9.31 in pre-market trading after France's Sanofi announced plans to buy the company in a $1.9 billion deal. SPAR...

Via Benzinga

IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability

September 07, 2021

From India Globalization Capital, Inc.

Via Business Wire

IGC Reports Financial Results for the June 30, 2021, Quarter

August 11, 2021

From India Globalization Capital, Inc.

Via Business Wire

A Forgettable Week For Alzheimer's Treatment Stocks: Two Of Our Top Names Come Back To Earth. This Is Why We Hedge. ↗

August 02, 2021

Screen capture via Cassava Sciences' video for their Simufilam Alzheimer's disease treatment. Two Alzheimer's Names Come Back To Earth In a post last week (An...

Via Benzinga

75 Biggest Movers From Friday ↗

July 26, 2021

Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global...

Via Benzinga

An Unforgettable Week For Alzheimer's Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Promising Treatments ↗

July 23, 2021

Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment. Two Stocks Spike On Alzheimer...

Via Benzinga

50 Stocks Moving In Friday's Mid-Day Session ↗

July 23, 2021

Gainers Xenetic Biosciences Inc (NASDAQ: XBIO) shares jumped 111.3% to $3.9299 on abnormally-high volume. The New Home Company Inc. (NYSE: NWHM) climbed 83% to $8.90 after the...

Via Benzinga

An Unforgettable Week For Alzheimer's Treatment Stocks ↗

July 23, 2021

Two of our recent top stocks spiked on news of potentially promising Alzheimer's treatments this week. They're both risky names, so we look at how to hold them without losing your shirt.

Via Talk Markets

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

IGC Pharma, Inc. Common Stock (NY:IGC)

All News about IGC Pharma, Inc. Common Stock

Resources